Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

Grade Last Price % Change Price Change
grade D 5.45 4.01% 0.21
CPRX closed up 4.01 percent on Monday, October 21, 2019, on 43 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical CPRX trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
Stochastic Reached Overbought Strength 4.01%
Overbought Stochastic Strength 4.01%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.83%
Narrow Range Bar Range Contraction 2.83%
NR7 Range Contraction 2.83%
Inside Day Range Contraction 2.83%
Wide Bands Range Expansion 2.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.41%
20 DMA Support Bullish 4.41%

Older signals for CPRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Health Pharmaceutical Pharmaceutical Industry California Medication Disorders Virotherapy Health Sciences Epilepsy Pharmaceutical Sciences Biomarin Pharmaceutical Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Novato Tourette Syndrome Treatment Of Epilepsy
Is CPRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.67
52 Week Low 1.85
Average Volume 2,392,039
200-Day Moving Average 4.3009
50-Day Moving Average 5.7059
20-Day Moving Average 5.0513
10-Day Moving Average 4.9845
Average True Range 0.3456
ADX 20.42
+DI 23.4313
-DI 21.348
Chandelier Exit (Long, 3 ATRs ) 5.6832
Chandelier Exit (Short, 3 ATRs ) 5.4468
Upper Bollinger Band 5.6696
Lower Bollinger Band 4.433
Percent B (%b) 0.82
BandWidth 24.480827
MACD Line -0.1361
MACD Signal Line -0.2242
MACD Histogram 0.0881
Fundamentals Value
Market Cap 460.81 Million
Num Shares 84.6 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -27.25
Price-to-Sales 0.00
Price-to-Book 6.97
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.88
Resistance 3 (R3) 5.86 5.69 5.81
Resistance 2 (R2) 5.69 5.58 5.70 5.79
Resistance 1 (R1) 5.57 5.51 5.63 5.59 5.76
Pivot Point 5.40 5.40 5.43 5.41 5.40
Support 1 (S1) 5.28 5.29 5.34 5.31 5.14
Support 2 (S2) 5.11 5.22 5.12 5.11
Support 3 (S3) 4.99 5.11 5.09
Support 4 (S4) 5.02